Bluejay Investor Presentation Deck

Board of Directors Douglas C. Wurth, Chairman Indranil "Neil" Dey, CEO Svetlana Dey Donald R. Chase Fred S. Zeidman Gary Gemignani J.P. Morgan ●●● ●● DIAGNOSTICS Skadden 20-year career at J.P. Morgan Chase (CEO of the International Private Bank & Alternative Investments, Asset Management) B.A Notre Dame University; J.D. University of Virginia School of Law; practiced law at Skadden, Arps, Meagher and Flom Involved in introducing Her2neu test for Herceptin and introduction of Erbitux Ph.D. in Biochemistry (UNESCO fellow) from BRC, Hungary; MBA (Fulbright Scholar) from Cambridge University, UK Co-founder of Bluejay; President & CEO of LMBRI LLC; 15 years+ of management experience in healthcare industry Masters Degree in Mathematics from the State University of Mari El Republic, Russia 35 years in executive roles at well-known community banks in New England B.S. Accounting, Western New England University 50+ years of corporate advisory experience; Chairman Emeritus University of Texas Health Science System Bachelor's degree from Washington University in St. Louis; Masters in Business Administration from New York University Senior executive with experience in life sciences, public companies, accounting/finance Prior experience with Acacia Pharma, Biodel, Prudential Financial, Gentium, Novartis, Wyeth and Arthur Andersen IMPATH" The Con Company Imbri merchants BANCSHARES INC westbank UNITED STATES MUSEUM ARTHUR ANDERSEN Copyright ©2023 Bluejay Diagnostics, Inc. All rights reserved in all slides | August 2023 17

View entire presentation